Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

EASD

2024/09/09-2024/09/13

Madrid (Spain)

60th edition of the Annual Meeting of the European Association for the Study of Diabetes (EASD)! 

With more than 11,000 prticipants, the EASD Annual Meeting is the largest diabetes congress of its kind in Europe, taking place every year in September/October. The EASD annual meeting will again be in a hybrid format to connect diabetologists and related fields in-person and virtually. The entire EASD scientific and industry programme will be live streamed on the Virtual Meeting platform and the content will be available until +/- 4 weeks after the congress. 
The congress brings together top experts, researchers and industry professionals from across the globe.

Being Diabetes one of the new main focus of the Company, this year we will participate with a key position in the Exhiition Space and 1 symposium.

EASD 0